Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for neurological disorders

T Friedmann1

  • 1Center for Molecular Genetics, School of Medicine, University of California at San Diego, La Jolla 92093.

Trends in Genetics : TIG
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene therapy for spinomuscular atrophy: a biomedical advance, a missed opportunity for more equitable drug pricing.

Gene therapy·2017
Same author

Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.

Brain research bulletin·2012
Same author

Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization.

Molecular and cellular neurosciences·2009
Same author

Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.

Acta biologica Hungarica·2003
Same author

The bioseparation needs for tomorrow.

Trends in biotechnology·2001
Same author

Stanfield Rogers: insights into virus vectors and failure of an early gene therapy model.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Genetic therapies show promise for central nervous system diseases and injuries. These treatments will target causative genes and neurotrophic factors impacting neuronal survival and function.

Area of Science:

  • Neuroscience
  • Genetics
  • Biomedical Engineering

Background:

  • Central nervous system (CNS) diseases and injuries represent a significant unmet medical need.
  • Current treatments for CNS disorders have limitations in addressing underlying pathology.
  • Advancements in genetic engineering offer new therapeutic avenues.

Purpose of the Study:

  • To explore the potential of genetic therapies for treating CNS diseases and injuries.
  • To identify key molecular targets for future CNS-focused genetic interventions.
  • To discuss the scope of genetic therapy applications in neurobiology.

Main Methods:

  • Review of current research in genetic therapy and neurobiology.
  • Analysis of potential therapeutic targets within the central nervous system.

Related Experiment Videos

  • Discussion of the mechanisms by which genetic therapies could restore neuronal function.

    • Main Results:

    • Genetic therapies are poised for clinical application in CNS disorders.
    • Therapeutic targets include causative genes, neurotrophic factors, and metabolic pathways.
    • These therapies aim to enhance neuronal survival, function, and neurotransmission.

    Conclusions:

    • Genetic therapies represent a highly promising future for treating a range of central nervous system conditions.
    • The strategic targeting of specific genes and neurotrophic factors will be crucial for therapeutic success.
    • Future research should focus on refining genetic delivery systems and understanding complex neural pathways.